A. Ylitalo

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Antti S Ylitalo, Antti Ylitalo, Antti S. Ylitalo, A Ylitalo, A. Ylitalo
Publication record
129 papers · 4,561 citations · H-index 37

PAPERS

10-year follow-up of patients with titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome.
20251 citationsauthor #3
Impact of Intraprocedural Pressure Changes on Hemodynamic Outcome During Self-Expanding TAVR
20230 citationsauthor #3
Smoking cessation and obesity-related morbidities and mortality in a 20-year follow-up study
202215 citationsauthor #2
Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study
202112 citationsauthor #6
Nighttime ambulatory pulse pressure predicts cardiovascular and all‐cause mortality among middle‐aged participants in the 21‐year follow‐up
20216 citationsauthor #2
Asystole episodes and bradycardia in patients with end-stage renal disease.
202113 citationsauthor #11
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction
202141 citationsauthor #66
Full feature selection for estimating KAP radiation dose in coronary angiographies and percutaneous coronary interventions
20205 citationsauthor #4
Peptide hormones and risk for future cardiovascular events among prediabetics: a 20-year follow-up in the OPERA study
20204 citationsauthor #2
Fluid overload is an independent predictor of atrial fibrillation in end-stage renal disease: A prospective study using insertable cardiac and body composition monitors .
20205 citationsauthor #10
Distribution of ischemic strokes in patients with atrial fibrillation: The FibStroke Study.
20198 citationsauthor #7
CHA2DS2-VASC AND HAS-BLED SCORES IN PREDICTING THE RISK OF STROKE VERSUS INTRACRANIAL BLEED: THE FIBSTROKE STUDY
20180 citationsauthor #8
MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation.
201882 citationsauthor #9
How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?
20182 citationsauthor #7
What's happening in Neurology® Clinical Practice
20184 citationsauthor #8
Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study).
201810 citationsauthor #8
Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
20178 citationsauthor #11
Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome
20175 citationsauthor #3
Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).
201720 citationsauthor #5
Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study
201714 citationsauthor #4
P4568Spontaneous and traumatic intracranial bleeds in patients with atrial fibrillation
20171 citationsauthor #7
Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score).
201736 citationsauthor #7
Impact of Calcified Target Lesions on the Outcome of Percutaneous Coronary Intervention for Acute Coronary Syndrome: Insights From the BASE ACS Trial
20174 citationsauthor #6
Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk
201749 citationsauthor #7
Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.
201622 citationsauthor #3
Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study
201614 citationsauthor #5
TCT-318 Ten-year All-cause Mortality after Simple versus Complex Stenting of Coronary Artery Bifurcation Lesions in the Randomized Nordic Bifurcation Study.
20161 citationsauthor #17
Abstract 12077: Stroke as the First Manifestation of Atrial Fibrillation
201662 citationsauthor #8
Abstract 13495: Ambulatory Blood Pressure Characteristics and Long-Term Risk for Atrial Fibrillation
20160 citationsauthor #3
Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).
201649 citationsauthor #5
Strokes after cardioversion of atrial fibrillation--The FibStroke study.
201637 citationsauthor #6
TCT-328: Long-term outcome after percutaneous coronary intervention with titaniumnitride- oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a five-year follow-up of the TITAX-AMI trial
20160 citationsauthor #13
Ambulatory Blood Pressure Characteristics and Long-Term Risk for Atrial Fibrillation
201623 citationsauthor #3
Renal sympathetic denervation in treating drug-resistant hypertension in a patient on hemodialysis.
20164 citationsauthor #4
Underuse of anticoagulation in stroke patients with atrial fibrillation – the FibStroke Study
201641 citationsauthor #6
Can We Predict the Failure of Electrical Cardioversion of Acute Atrial Fibrillation? The FinCV Study
201538 citationsauthor #7
Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study
20158 citationsauthor #8
Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial
201512 citationsauthor #6
Early neointimal coverage and vasodilator response following biodegradable polymer sirolimus-eluting vs. durable polymer zotarolimus-eluting stents in patients with acute coronary syndrome –HATTRICK-OCT trial.
201527 citationsauthor #6
LACK OF ANTICOAGULATION IS COMMON IN PATIENTS WITH ATRIAL FIBRILLATION WHO DEVELOP AN ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK: THE FIBSTROKE STUDY
20140 citationsauthor #5
Transthoracic echocardiography for non-invasive assessment of coronary vasodilator function after DES implantation.
20147 citationsauthor #3
Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial
20149 citationsauthor #5
Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation
20147 citationsauthor #4
Prognostic significance of impaired baroreflex sensitivity assessed from Phase IV of the Valsalva maneuver in a population-based sample of middle-aged subjects.
201425 citationsauthor #5
Mid-term clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: OPTIMAX first-in-man study.
20143 citationsauthor #3
Heart Rate Variability Findings as a Predictor of Atrial Fibrillation in Middle‐Aged Population
201447 citationsauthor #5
INTRACRANIAL BLEEDINGS AND ISCHEMIC STROKES DURING WARFARIN TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION: THE FIBSTROKE STUDY
20140 citationsauthor #5
Bacterial Signatures in Thrombus Aspirates of Patients With Myocardial Infarction
2013106 citationsauthor #4
Long-term results after simple versus complex stenting of coronary artery bifurcation lesions
20133 citationsauthor #19
confirms the linkage to the chromosome 5q13-14 in Finnish families Candidate locus analysis of familial ascending aortic aneurysms and dissections
20130 citationsauthor #2
Heart rate variability as predictor of atrial fibrillation in middle-aged population
20130 citationsauthor #5
Erratum to: Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial
20131 citationsauthor #5
Renal impairment and prognosis of patients with AF undergoing PCI - The AFCAS trial
20130 citationsauthor #6
Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS).
201332 citationsauthor #11
Vascular healing early after titanium-nitride-oxide-coated stent implantation assessed by optical coherence tomography.
20138 citationsauthor #4
Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment--the FinPAC study.
201343 citationsauthor #4
Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study.
201370 citationsauthor #3
Response to letters regarding article, "Bacterial signatures in thrombus aspirates of patients with myocardial infarction".
20131 citationsauthor #4
Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial
201320 citationsauthor #10
Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results.
2013179 citationsauthor #21
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
201345 citationsauthor #2
[Treatment of acute ST-elevation myocardial infarction].
20131 citationsauthor #1
Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study.
2013241 citationsauthor #5
High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults
201232 citationsauthor #3
Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study
201214 citationsauthor #3
Sunday, 26 August 2012
20125 citationsauthor #4720
Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial.
201212 citationsauthor #2
Poster Session Wednesday 5 December all day Display * Determinants of left ventricular performance
20121 citationsauthor #179
Late stent thrombosis of a second-generation drug- eluting stent.
20121 citationsauthor #3
Nondipping pattern and carotid atherosclerosis in a middle-aged population: OPERA Study.
201255 citationsauthor #3
[Myocardial infarct during pregnancy].
20120 citationsauthor #2
Tuesday, 28 August 2012
20121 citationsauthor #791
Early vascular healing after endothelial progenitor cell capturing stent implantation.
201211 citationsauthor #3
Monday, 27 August 2012
20125 citationsauthor #1066
A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial.
201264 citationsauthor #12
Long-term safety of drug-eluting stents in patients on warfarin treatment
201218 citationsauthor #5
Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
201228 citationsauthor #4
Increased B-Type Natriuretic Peptide Concentration Is Associated with Reduced Coronary Vasoreactivity in Patients with Dilated Cardiomyopathy but Not in Healthy Young Subjects
20110 citationsauthor #4
Natriuretic peptides and collagen biomarkers in patients with medical treatment for hypertension
20117 citationsauthor #3
ST-ELEVATION MYOCARDIAL INFARCTION IS OFTEN DUE TO INFECTION WITH PATHOGENIC BACTERIA ASSOCIATED WITH PERIODONTAL DISEASE
20110 citationsauthor #4
Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry.
201138 citationsauthor #2
Pooled analysis of trials comparing titanium-nitride-oxide-coated stents with paclitaxel-eluting stents in patients undergoing coronary stenting.
201010 citationsauthor #3
Moderated Posters session IV: Viability and recovery of systolic function. The echo approach * Friday 10 December 2010, 15:30-16:30
201013 citationsauthor #56
Drug-eluting stents in patients on long-term oral anticoagulation therapy: a mission impossible?
20106 citationsauthor #2
Preoperative warfarin treatment and outcome of coronary artery bypass graft surgery.
201013 citationsauthor #7
Titanium-nitride-oxide-coated Titan-2 bioactive coronary stent: a new horizon for coronary intervention
20108 citationsauthor #2
Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study.
201050 citationsauthor #5
Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population.
201037 citationsauthor #3
Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: A prospective serial venographic study
200918 citationsauthor #2
Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment?
200930 citationsauthor #6
Poster Session 2: Pacing leads
20090 citationsauthor #23
Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction
200945 citationsauthor #2
Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment.
200858 citationsauthor #5
Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial.
200850 citationsauthor #2
Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcation study 14-month follow-up results.
200866 citationsauthor #20
Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.
2008120 citationsauthor #5
Venous Obstruction After Pacemaker Implantation
2007117 citationsauthor #3
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
2007297 citationsauthor #3
Safety of percutaneous coronary intervention during uninterrupted anticoagulant treatment
20073 citationsauthor #3
Safety of glycoprotein IIb/IIIa inhibitors in warfarin treated patients undergoing PCI
20070 citationsauthor #3

TIMELINE

1996 176 citations

1998 26 citations

1999 99 citations

2000 145 citations

2001 63 citations

2003 36 citations

2004 267 citations

2005 162 citations

2006 826 citations

2007 417 citations

2008 294 citations

2009 93 citations

2010 137 citations

2011 45 citations

2012 247 citations

2013 750 citations

2014 98 citations

2015 85 citations

2016 253 citations

2017 137 citations

2018 98 citations

2019 8 citations

2020 14 citations

2021 72 citations

2022 15 citations

2023 0 citations

2025 1 citations

Unknown 0 citations

A. Ylitalo

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT